Skip to content
DataLookout
Menu

REMOV-HDxNCT07348536

Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date changed from estimate of Apr 2026 to Nov 1, 2026 Show 4 more changesShow less
    • Eligibility criteria expanded, about 6 words
    • Completed without a posted recruiting period
    • Start date changed from estimate of Apr 2026 to Apr 1, 2026
    • Secondary endpoints: details revised at 1 of 3 entries
  2. Notable Start date: Aug 10, 2025 to Apr 2026v2 Show 4 more changesShow less
    • Trial status: Recruiting to Not Yet Recruiting
    • Primary completion date: Oct 15, 2025 to Apr 2026
    • Study completion date: Jan 20, 2026 to Dec 2029
    • Site details revised
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Global Removal Score of Uremic Toxins
Timeframe: During each dialysis intervention session (pre- and post-dialysis measurements), over a 4-week study period

Secondary (3)

Removal Rate of Individual Medium-Sized Uremic Toxins
Removal Rate of Small Solutes
Beta-2 Microglobulin Clearance by Kt/V

Arms and interventions

Expanded Hemodialysis Prescriptions and High-Volume Online HemodiafiltrationExperimental

Participants will receive three expanded hemodialysis sessions with different treatment durations (180, 210, and 240 minutes) in randomized order, followed by one session of high-volume online hemodiafiltration. Blood samples will be collected before and after each session to assess uremic toxin removal.

Devices: Expanded Hemodialysis With Medium Cut-Off Membrane, High-Volume Online Hemodiafiltration

Sites

1 site in 1 country

  • Instituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiranMexico City, Mexico City, Mexico